Cargando…
Study on Attenuating Angiogenesis and Epithelial–Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2
OBJECTIVE: To investigate the role of MAGE family member C2 in angiogenesis and epithelial–mesenchymal transition of non-small cell lung carcinoma. METHODS: The Cancer Genome Atlas data set was analyzed to filter the highly expressed gene melanoma antigen family C2 in non-small cell lung carcinoma....
Autores principales: | Jiang, Sicong, Liu, Xi, Li, Daojing, Yan, Meiying, Ju, Cheng, Sun, Jun, Jiang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131299/ https://www.ncbi.nlm.nih.gov/pubmed/30198403 http://dx.doi.org/10.1177/1533033818797587 |
Ejemplares similares
-
MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
por: Yang, Fan, et al.
Publicado: (2014) -
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition
por: Gu, Xuefeng, et al.
Publicado: (2019) -
Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
por: Chae, Young Kwang, et al.
Publicado: (2018) -
Establishment of MAGEC2‐knockout cells and functional investigation of MAGEC2 in tumor cells
por: Wang, Jingjing, et al.
Publicado: (2016) -
Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)